From Hans Selye's Discovery of Biological Stress to the Identification of Corticotropin-Releasing Factor Signaling Pathways

被引:57
作者
Tache, Yvette [1 ]
Brunnhuber, Stefan [2 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[2] Univ Wurzburg, Wurzburg, Germany
来源
STRESS, NEUROTRANSMITTERS, AND HORMONES: NEUROENDOCRINE AND GENETIC MECHANISMS | 2008年 / 1148卷
关键词
CRF; CRF receptors; CRF antagonists; colonic motor function; irritable bowel syndrome; stress;
D O I
10.1196/annals.1410.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Selye pioneered the concept of biological stress in 1936, culminating in the identification of the corticotropin-releasing factor (CRF) signaling pathways by Vale's group in the last two decades. The characterization of the 41 amino-acid CRF and other peptide members of the mammalian CRF family, urocortin 1, urocortin 2, and urocortin 3, and the cloning of CRF1 and CRF2 receptors, which display distinct affinity for CRF ligands, combined with the development of selective CRF receptor antagonists enable us to unravel the importance of CRF1 receptor in the stress-related endocrine (activation of pituitary-adrenal axis), behavioral (anxiety/depression, altered feeding), autonomic (activation of sympathetic nervous system), and immune responses. The activation of CRF1 receptors is also one of the key mechanisms through which various stressors impact the gut to stimulate colonic propulsive motor function and to induce hypersensitivity to colorectal distension as shown by the efficacy of the CRF1 receptor antagonists in blunting these stress-related components. The importance of CRF1 signaling pathway in the visceral response to stress in experimental animals provided new therapeutic approaches for treatment of functional bowel disorder such as irritable bowel syndrome, a multifactor functional disorder characterized by altered bowel habits and visceral pain, for which stress has been implicated in the pathophysiology and is associated with anxiety-depression in a subset of patients.
引用
收藏
页码:29 / 41
页数:13
相关论文
共 131 条
  • [1] Human CRF2 α and β splice variants:: pharmacological characterization using radioligand binding and a luciferase gene expression assay
    Ardati, A
    Goetschy, V
    Gottowick, J
    Henriot, S
    Valdenaire, O
    Deuschle, U
    Kilpatrick, GJ
    [J]. NEUROPHARMACOLOGY, 1999, 38 (03) : 441 - 448
  • [2] Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats
    Ataka, Koji
    Kuge, Tomoo
    Fujino, Kazunori
    Takahashi, Toku
    Fujimiya, Mineko
    [J]. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2007, 133 (02): : 136 - 145
  • [3] CRF and CRF receptors: Role in stress responsivity and other behaviors
    Bale, TL
    Vale, WW
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 525 - 557
  • [4] Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior
    Bale, TL
    Picetti, R
    Contarino, A
    Koob, GF
    Vale, WW
    Lee, KF
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (01) : 193 - 199
  • [5] Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay
    Barreau, Frederick
    Cartier, Christel
    Leveque, Mathilde
    Ferrier, Laurent
    Moriez, Raphael
    Laroute, Valerie
    Rosztoczy, Andras
    Fioramonti, Jean
    Bueno, Lionel
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2007, 580 (01): : 347 - 356
  • [6] Elevated concentrations of CRF in the locus coeruleus of depressed subjects
    Bissette, G
    Klimek, V
    Pan, J
    Stockmeier, C
    Ordway, G
    [J]. NEUROPSYCHOPHARMACOLOGY, 2003, 28 (07) : 1328 - 1335
  • [7] Bittencourt JC, 1999, J COMP NEUROL, V415, P285
  • [8] WATER-AVOIDANCE STRESS-INDUCED C-FOS EXPRESSION IN THE RAT-BRAIN AND STIMULATION OF FECAL OUTPUT - ROLE OF CORTICOTROPIN-RELEASING FACTOR
    BONAZ, B
    TACHE, Y
    [J]. BRAIN RESEARCH, 1994, 641 (01) : 21 - 28
  • [9] Bremner JD, 1997, AM J PSYCHIAT, V154, P624
  • [10] Management of the irritable bowel syndrome
    Camilleri, M
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 652 - 668